Literature DB >> 9202270

A comparison of proliferation indices in human anterior pituitary adenomas using formalin-fixed tissue and in vitro cell culture.

S L Atkin1, V L Green, L J Hipkin, A M Landolt, P M Foy, R V Jeffreys, M C White.   

Abstract

The authors compared detection methods for cell proliferation in human anterior pituitary adenomas using histological sections and dispersed cell culture. After tumor cells had been grown for 4 days in dispersed culture, bromodeoxyuridine (BUdR), proliferating cell nuclear antigen (PCNA), and Ki-67 were compared by double immunostaining and contrasted with single staining of PCNA and Ki-67 indices in the corresponding histological sections from 12 human pituitary adenomas. In vitro, the BUdR labeling index was positive in six of 12 tumors (range < 0.1-5.1%), 10 of 12 tumors were PCNA-positive (range < 0.1-100%), and Ki-67 was positive in 10 of 12 adenomas (range < 0.1-8%). In vitro, BUdR and Ki-67 gave similar proliferative indices for 10 of 12 adenomas. In vivo, the PCNA labeling index was positive in 12 of 12 adenomas (range 0.9-95%) and Ki-67 was positive in 11 of 12 adenomas (range < 0.1-2%). Tumors with a labeling index less than 0.1% were considered to be negative for proliferation. High PCNA values were found in vitro and in vivo, whereas Ki-67 labeling indices were similar in vitro and in vivo for nine of 12 adenomas. It is concluded that Ki-67 proliferative indices in vivo reflect those found in vitro, at least after 4 days in dispersed culture, but that PCNA overestimates pituitary adenoma proliferation in histological sections as well as in dispersed culture.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202270     DOI: 10.3171/jns.1997.87.1.0085

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  8 in total

Review 1.  The emerging role of pituitary tumor transforming gene in tumorigenesis.

Authors:  Jacob Tfelt-Hansen; Deepthi Kanuparthi; Naibedya Chattopadhyay
Journal:  Clin Med Res       Date:  2006-06

2.  Cyclins D1 and D3 and topoisomerase II alpha in inactive pituitary adenomas.

Authors:  W Saeger; S Schreiber; D K Lüdecke
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

3.  Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody.

Authors:  L Mastronardi; A Guiducci; C Spera; F Puzzilli; F Liberati; G Maira
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

4.  Correlation between PCNA expression and AgNOR dots in pituitary adenomas.

Authors:  M Klencki; I Kurnatowska; D Słowińska-Klencka; A Lewiński; M Pawlikowski
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 5.  Are markers of proliferation valuable in the histological assessment of pituitary tumours?

Authors:  H E Turner; J A Wass
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

6.  Nuclear accumulation of basic fibroblast growth factor as a predictor for the recurrence of pituitary adenomas.

Authors:  Shinji Fukui; Naoki Otani; Hiroshi Nawashiro; Akiko Yano; Takahito Miyazawa; Akira Ohnuki; Nobusuke Tsuzuki; Hiroshi Katoh; Shoichiro Ishihara; Takamoto Suzuki; Katsuji Shima
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

7.  Adrenocorticotropin-Producing Pituitary Carcinoma with Expression of c-erbB-2 and High PCNA Index: A Comparative Study with Pituitary Adenomas and Normal Pituitary Tissues.

Authors:  Vania Nose-Alberti; Maria Isabel S. Mesquita; Luciana C. Martin; Marcia J. Kayath
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

8.  Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas.

Authors:  L Mastronardi; A Guiducci; F Puzzilli
Journal:  BMC Cancer       Date:  2001-08-21       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.